Skip to main content
. 2015 May 29;10(5):e0127549. doi: 10.1371/journal.pone.0127549

Fig 5. ND-13 blood-brain-barrier penetration.

Fig 5

C57/bl6 mice were injected with FITC-Albumin (FITC-Alb) to visualize intact blood vessels. FITC conjugated TAT peptide (FITC-TAT), FITC conjugated ND-13 lacking the TAT sequence (ND-13C-FITC) or FITC conjugated full length ND-13 (ND-13-FITC) were injected subcutaneous (SC) and monitored by CellVizio system for additional 30 min. Time dependent accumulation of the fluorescent signal in the brain parenchyma around the blood vessels was observed when mice were administrated with either TAT-FITC or ND-13-FITC but not with ND-13C, indicating that the TAT-derived cell penetrating peptide enables ND-13 to penetrate the BBB.